Monthly Archives: February 2025

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Quetiapine 50mg, 150mg, 200mg, 300mg and 400mg modified-release tablets MSN/2025/006 Tier 2 medium impact Date of issue: 10th February 2025 There are supply constraints affecting quetiapine 50mg, 150mg, 200mg, 300mg and 400mg modified-release tablets (see supply summary table in Supporting information). [...]

The post Medicine Supply Notification: Quetiapine 50mg, 150mg, 200mg, 300mg and 400mg modified-release tablets appeared first on Community Pharmacy England.

The NHS Business Services Authority (NHSBSA) produces a quarterly newsletter called “Hints & Tips for dispensing contractors”. The latest edition (Issue 58) contains some useful information and advice on: Tax credits to end on Saturday 5 April 2025 Pharmacy First – completing a supply within the Patient Group Direction (PGD) Endorsing Not Dispensed items Real [...]

The post NHSBSA ‘Hints & Tips’ – Issue 58 appeared first on Community Pharmacy England.

Drug alert number: EL (25)A/05 Date issued: 5 February 2025 CNX Therapeutics is recalling the batches listed in this notification as a precautionary measure due to a small number of packs that contain an additional tablet of Nitrofurantoin. The registered product is a capsule containing powder and two yellow tablets. Nitrofurantoin 100 mg Prolonged-Release capsules [...]

The post MHRA Class 2 Medicines recall: Nitrofurantoin 100 mg Prolonged-Release capsules (CNX Therapeutics) appeared first on Community Pharmacy England.

Today, the GPhC has updated its guidance for pharmacies that provide pharmacy services at a distance, including online, to introduce extra safeguards. This has been done to help prevent people from receiving medicines that are not clinically appropriate for them and could cause harm.  This guidance has been updated in response to concerns the GPhC [...]

The post GPhC publish updated guidance for online pharmacy services appeared first on Community Pharmacy England.

According to the Shortage of Pancreatic enzyme replacement therapy (PERT) National Patient Safety Alert (NPSA) published on 18 December 2024, Creon® will remain in limited supply until 2026 and alternatives such as Nutrizym® 22 capsules and Pancrex V® capsules and powder are intermittently available but are unable to fully cover the gap in supply. One of the [...]

The post Supply of unlicensed PERT preparations appeared first on Community Pharmacy England.